Quantcast
Viewing all articles
Browse latest Browse all 2851

23andMe to shut down its therapeutics division

23andMe is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company said Monday evening. The company said it’s exploring all strategic options for its therapeutic programs, including licensing ...

Viewing all articles
Browse latest Browse all 2851

Trending Articles